135 related articles for article (PubMed ID: 12170380)
1. An optimum anti-melanoma response in mice immunized with fibroblasts transfected with DNA from mouse melanoma cells requires the expression of both syngeneic and allogeneic MHC-determinants.
de Zoeten EF; Markovic D; Cohen EP
Gene Ther; 2002 Sep; 9(17):1163-72. PubMed ID: 12170380
[TBL] [Abstract][Full Text] [Related]
2. Resistance to melanoma in mice immunized with semiallogeneic fibroblasts transfected with DNA from mouse melanoma cells.
de Zoeten EF; Carr-Brendel V; Cohen EP
J Immunol; 1998 Mar; 160(6):2915-22. PubMed ID: 9510195
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral injection of IL-secreting syngeneic/allogeneic fibroblasts transfected with DNA from breast cancer cells prolongs the survival of mice with intracerebral breast cancer.
Lichtor T; Glick RP; Lin H; O-Sullivan I; Cohen EP
Cancer Gene Ther; 2005 Aug; 12(8):708-14. PubMed ID: 15803143
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic properties of DNA-based fibroblast and dendritic cell vaccines in mice with squamous carcinoma.
O-Sullivan I; Kim TS; Chopra A; Cohen EP
Anticancer Res; 2006; 26(2A):873-84. PubMed ID: 16619482
[TBL] [Abstract][Full Text] [Related]
5. Treatment of breast cancer with fibroblasts transfected with DNA from breast cancer cells.
de Zoeten E; Carr-Brendel V; Markovic D; Taylor-Papadimitriou J; Cohen EP
J Immunol; 1999 Jun; 162(11):6934-41. PubMed ID: 10352316
[TBL] [Abstract][Full Text] [Related]
6. Prolongation of the survival of breast cancer-bearing mice immunized with GM-CSF-secreting syngeneic/allogeneic fibroblasts transfected with a cDNA expression library from breast cancer cells.
Kim TS; Jung MY; Cho D; Cohen EP
Vaccine; 2006 Oct; 24(42-43):6564-73. PubMed ID: 16837111
[TBL] [Abstract][Full Text] [Related]
7. Immunization with interleukin-2-secreting allogeneic cells transfected with DNA from mouse melanoma cells induces immune responses that prolong the lives of mice with melanoma.
Sun T; Carr-Brendel V; De Zoeten EF; Cohen EP
Cancer Gene Ther; 1998; 5(2):110-8. PubMed ID: 9570302
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-2-secreting mouse fibroblasts transfected with genomic DNA from murine melanoma cells prolong the survival of mice with melanoma.
Kim TS; Cohen EP
Cancer Res; 1994 May; 54(10):2531-5. PubMed ID: 8168073
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-2-secreting mouse fibroblasts transfected with genomic DNA from murine neoplasms induce tumor-specific immune responses that prolong the lives of tumor-bearing mice.
Sun T; Kim TS; Waltz MR; Cohen EP
Cancer Gene Ther; 1995 Sep; 2(3):183-90. PubMed ID: 8528961
[TBL] [Abstract][Full Text] [Related]
10. Enhanced immunity to breast cancer in mice immunized with fibroblasts transfected with a complementary DNA expression library from breast cancer cells: Enrichment of the vaccine for immunotherapeutic cells.
Kim TS; Chopra A; O-Sullivan IS; Cohen EP
J Immunother; 2006; 29(3):261-73. PubMed ID: 16699369
[TBL] [Abstract][Full Text] [Related]
11. Immunity to breast cancer in mice immunized with fibroblasts transfected with a cDNA expression library derived from small numbers of breast cancer cells.
Sung Kim T; Cohen EP
Cancer Gene Ther; 2005 Nov; 12(11):890-9. PubMed ID: 15905859
[TBL] [Abstract][Full Text] [Related]
12. The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status.
Douin-Echinard V; Bornes S; Rochaix P; Tilkin AF; Peron JM; Bonnet J; Favre G; Couderc B
Cancer Gene Ther; 2000 Dec; 7(12):1543-56. PubMed ID: 11228533
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
[TBL] [Abstract][Full Text] [Related]
14. Co-expression of immunogenic determinants by the same cellular immunogen is required for the optimum immunotherapeutic benefit in mice with melanoma.
Xu W; de Zoeten E; Carr-Brendel V; Cohen EP
Cancer Immunol Immunother; 1998 Jan; 45(5):217-24. PubMed ID: 9439644
[TBL] [Abstract][Full Text] [Related]
15. Immunization with interleukin-2-secreting allogeneic mouse fibroblasts expressing melanoma-associated antigens prolongs the survival of mice with melanoma.
Kim TS; Russell SJ; Collins MK; Cohen EP
Int J Cancer; 1993 Nov; 55(5):865-72. PubMed ID: 8244584
[TBL] [Abstract][Full Text] [Related]
16. DNA vaccination of HSP105 leads to tumor rejection of colorectal cancer and melanoma in mice through activation of both CD4 T cells and CD8 T cells.
Miyazaki M; Nakatsura T; Yokomine K; Senju S; Monji M; Hosaka S; Komori H; Yoshitake Y; Motomura Y; Minohara M; Kubo T; Ishihara K; Hatayama T; Ogawa M; Nishimura Y
Cancer Sci; 2005 Oct; 96(10):695-705. PubMed ID: 16232202
[TBL] [Abstract][Full Text] [Related]
17. Immunization with truncated sequence of Telomerase Reverse Transcriptase induces a specific antitumor response in vivo.
Qiu J; Li GW; Sui YF; Sun YJ; Huang YY; Si SY; Ge W
Acta Oncol; 2007; 46(7):961-8. PubMed ID: 17917827
[TBL] [Abstract][Full Text] [Related]
18. Immunization with interleukin-2/interferon-gamma double cytokine-secreting allogeneic fibroblasts prolongs the survival of mice with melanoma.
Kim TS; Xu WS; Sun T; Cohen EP
Melanoma Res; 1995 Aug; 5(4):217-27. PubMed ID: 7496156
[TBL] [Abstract][Full Text] [Related]
19. Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts.
Lee J; Fassnacht M; Nair S; Boczkowski D; Gilboa E
Cancer Res; 2005 Dec; 65(23):11156-63. PubMed ID: 16322266
[TBL] [Abstract][Full Text] [Related]
20. Major histocompatibility gene therapy: the importance of haplotype and beta 2-microglobulin.
Salamone FN; Gleich LL; Li YQ; Stambrook PJ
Laryngoscope; 2004 Apr; 114(4):612-5. PubMed ID: 15064612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
